Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Health CatalystHCAT -4.00%49 3-1 Month Momentum % is 38.10% as of Jul. 21, 2026. GuruFocus rates HCAT with a GF Score™ of 49/100 and a GF Value™ of $4.97 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 678 Healthcare Providers & Services companies, Health Catalyst ranks better than 94.25% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-21), Health Catalyst's 3-1 Month Momentum % is 38.10%.
The industry rank for Health Catalyst's 3-1 Month Momentum % or its related term are showing as below:
HCAT's 3-1 Month Momentum % is ranked better than 94.25% of 678
companies
in the Healthcare Providers & Services industry
Industry Median: -4.54
vs HCAT: 38.10
Health Catalyst (NAS:HCAT) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Health Catalyst 3-1 Month Momentum % Related Terms
HCAT vs SY, AMWL, OPRX: 3-1 Month Momentum % Comparison
For the Health Information Services subindustry, Health Catalyst's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Catalyst 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Health Catalyst's 3-1 Month Momentum % falls into.
Health Catalyst (NAS:HCAT) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Catalyst (HCAT) has a 3-1 Month Momentum % of 38.10% as of Jul. 21, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Health Catalyst and its competitors. According to the industry distribution chart, Health Catalyst ranks #39 out of 678 companies in the Healthcare Providers & Services industry, placing it in the top 5.8%.
Is Health Catalyst's 3-1 Month Momentum % too high?
Health Catalyst's current 3-1 Month Momentum % is 38.10%. Based on the distribution chart, Health Catalyst ranks #39 out of 678 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Health Catalyst has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Health Catalyst's 3-1 Month Momentum % compare to SY and AMWL?
According to the Healthcare Providers & Services industry distribution chart, Health Catalyst ranks #39 out of 678 companies for 3-1 Month Momentum %. This places Health Catalyst in the top 6% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Health Catalyst and its competitors. Health Catalyst's current 3-1 Month Momentum % is 38.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Catalyst stock overvalued right now?
Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $4.97, compared to a current price of $2.16 — trading 56.5% below its estimated fair value. The current 3-1 Month Momentum % is 38.10%. Health Catalyst's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Health Catalyst (HCAT), the current 3-1 Month Momentum % is 38.10% as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health Catalyst (HCAT) Overvalued in 2026?
Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued.
The current stock price of $2.16 is trading 56.5% below its estimated GF Value™ of $4.97.
GuruFocus considers Health Catalyst to be Possible Value Trap.
Key valuation signals for HCAT:
3-1 Month Momentum %: 38.10%
GF Value™: $4.97 vs. price of $2.16 (56.5% below fair value)
No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
49GF Score
Get the complete analysis for HCAT
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HCAT has been successfully added to your 
